Academic Medical Center (AMC)
Meibergdreef 9
1105 AZ Amsterdam
Website Academic Medical Center
E-mail Amsterdam Medical Center
T +31 (0)20 566 50 56
F +31 (0)20 566 91 68

Employees in Amsterdam: 6,500
Employees in R&D: 1,400
Year of foundation: 1983

Company Profile

Science and Technologies or Services

AMC is active in the following research fields:

• Cardiovascular Diseases
• Gastr-intestinal diseases
• Immunity and Infections
• Metabolic Disorders
• Neurologic and Psychiatric Disorders
• Oncology
• Public Health and Epidemiology

AMC also offers advanced facilities and highly qualified personnel in the areas of gene and cell therapies, viral vector production, genomics, proteomics, metabolomics, bioinformatics, imaging, and animal models.

Alliances

AMC spin-offs:

• AIMM Therapeutics
• AMCAS
• Amsterdam Molecular Therapeutics (AMT)
• Arthrogen
• Hep-Art Medical Devices
• IATEC
• Macrozyme
• MicroVision Medical
• Primagen
• Valletta Health

Keywords

• Academic hospital
• Medical research
• License opportunities
• Spin-off companies
  

Alan Turing Institute
Louis Armstrongweg 84
1311 RL Almere
Website
E-mail
T +31 (0)36 5345985

Employees: 15
Employees in R&D: 9
Year of foundation: 2009

Company Profile

The Alan Turing Institute is dedicated to innovative scientific research and education. We reiterate that we aim at an interdisciplinary approach to health-related research, particularly targeted at individualized disease treatment. We have experts in the fields of Artificial Intelligence, Obesity, Female Sexual Dysfunction, Cognitive and Affective neuroscience. We aim for the further development of our multidisciplinary research method through collaboration with external parties working in the medical domain, in cooperation with universities to safeguard and corroborate the institute's academic status and ambition.

Science and Technologies or Services

Although there is a growing interest for the individual patient in health care and health science in general, our approach is unique in that it employs techniques from artificial intelligence, and agent technology in particular, to reach its goals. In particular, knowledge from sources as heterogeneous as medicine, biology, psychology and psychiatry may each be represented by their own agents and agents may each have their own method of reasoning. Based on information available about a patient and the agents' own instruction sets, agents can reason on chains of causes and effects. In other words: our knowledge based systems structure knowledge and can reason with this knowledge in such a way that we can make more refined diagnoses and can predict prevention and treatment for individual patients based on their unique constellation.

Alliances

• Emotional Brain BV
• UvA
• UU
• Child Obesity Clinic (Almere)

Keywords

• Obesity
• Female Sexual Dysfunction
• Artificial Intelligence
• Multi Agent Systems
• Cognitive Reserve

AMC Medical Business Park
Meibergdreef 5
1105 AZ Amsterdam
Website AMC Medical Business Park
E-mail AMC Medical Business Park
T +31 (0)20 566 41 36
F +31 (0)20 566 91 59

Employees in Amsterdam: 2
Employees in R&D:
Year of foundation:

Company Profile

The Medical Business Park (MBP) is currently under development at the site of the Academic Medical Center Amsterdam (AMC). The MBP is intended for companies which wish to develop products and services in the area of (bio)medical sciences together with, or with the support of, the AMC. It is the place where they draw their future. The AMC places a high value on the exchange and broadening of knowledge, and also wishes to make better use of knowledge from its own research. AMC’s technology transfer office, Bureau Kennis Transfer (BKT), plays an essential role here. BKT facilitates patenting, partnering, due diligence and control in relation to all (commercial) management aspects of research findings, technology transfer and the foundation of spin-off companies.

The AMC offers these companies a broad package of facilities and support, including access to patients for research and R&D collaborations with scientifically well-known groups and, through BKT, a professional office which efficiently handles e.g. patent- or R&D contract related matters. A setting and synergy of this kind means exploring and developing new areas becomes possible.

The AMC traditionally has strong roots in a number of wide-ranging research areas: infectious diseases and immunology, metabolic disorders, cardiovascular disorders, stomach, intestinal and liver disorders, neurological and psychiatric disorders, public health, and to an increasing extent also in oncology.

Science and Technologies or Services

One of the major services of the MBP Development Office will be the support of companies regarding business development, networking and supply facilities as e.g. accountancy, patenting, partnering, due diligence and control in relation to all (commercial) management aspects of research findings, technology transfer and the foundation of spin-off companies.

Alliances

• AMC
• Gemeente Amsterdam

Keywords

• Biopharmaceuticals
• Medical devices
• Patient care systems
• Infectious diseases
• Immunology
• Metabolic disorders
• Cardiovascular disorders
• Stomach, intestinal and liver disorders
• Neurological and psychiatric disorders
• Public health
• Oncology
• Science park
  
  

ACE @ Science Park
Science Park 402
1098 XH Amsterdam
Website
E-mail
T +31 (0)20 525 79 52

Employees in Amsterdam: 3
Employees in R&D: 0
Year of foundation: 2007

Company profile

The City of Amsterdam is the national leader in its concentration of both scientists and research institutes. It is home to the science faculties and research institutes of the University of Amsterdam (UvA), the Vrije University (VU), the Academic Medical Centre (AMC) of the University of Amsterdam, the Medical Centre of the VU, and the institutes of the Netherlands Organisation for Scientific Research (NWO). The level of scientific and technological research is therefore world class.

Many research projects result in market-oriented innovations. This has a positive impact on the economy and society as a whole. However, the commercialization process whereby scientific innovations are brought to the market is still relatively undeveloped. Scientists lack entrepreneurial and business skills, whereas business people do not easily come into contact with the innovations originating from the research conducted at Science Park Amsterdam and the various scientific faculties.

Amsterdam Center for Entrepreneurship @ Science Park was established to foster education in entrepreneurship, stimulate and support innovative startups based on research done at Science Park Amsterdam institutes and at the Faculty of Science of the University of Amsterdam. ACE @ Science Park aims to attracts students, researchers, entrepreneurs, investors and companies to start and support new ventures at Science Park Amsterdam and become the ‘Amsterdam hub’ for science and technology entrepreneurship.

Science and Technologies or Services

Entrepreneurship education is offerd by the Faculty of Economics and Business by the University of Amsterdam Business School and by ACE @ Science Park. Entrepreneurship is offered for Bachelor, Masters and MBA students. In addition ACE @ Science Park offers workshops and seminars on science and technology entrepreneurship to faculty, Ph.D. and post-docs.

Alliances

• University of Amsterdam;
• Science park Amsterdam;
• Amsterdam Center for Entrepreneurship.

Keywords

• Entrepreneurship;
• Center of Entrepreneurship;
• Science Park Amsterdam;
• Education;
• Incubation;
• Valorisation;
• Research;
• Business;
• Technology.

Australian Trade Commission
Borneokade 125
1019 XC Amsterdam
Website Australian Trade Commission
E-mail Australian Trade Commission
T +31 (0)20 419 85 07
F +31 (0)20 419 85 08

Employees in Amsterdam: 1
Employees in R&D: 0
Year of foundation:

Company Profile

Alliances

AusBiotech

Central Veterinary Institute (CVI) of Wageningen UR
P.O. Box 65
8200 AB Lelystad
Website Central Veterinary Institute
E-mail Central Veterinary Institute
T +31 (0)320 23 88 00
F +31 (0)320 23 86 68

Employees in Amsterdam:
Employees in R&D:
Year of foundation:

Company Profile

The Central Veterinary Institute carries out numerous activities. It does research for government and commercial companies and it advises on developing effective policies with regard to control animal diseases. The Institute closely follows international developments and is often the initiator of new research programmes. Its own vision and strategic investments in research and development regularly lead to new developments and new knowledge, thus ensuring that the Central Veterinary Institute remains an attractive organisation for its clients.
The areas in which the Central Veterinary Institute works cover the entire range of diseases (caused by viruses, bacteria, prions and parasites) found among agricultural livestock, fish and shellfish and wild animals. The Institute also studies pathogenic organisms in animals that form a threat to humans (zoonoses).
The staff of about 280 highly qualified people undertakes research for a large group of clients. The research varies from specialist to multi-disciplinary. For research the focus is always on the concepts of quality and independence. The Central Veterinary Institute is part of Wageningen UR and has an annual turnover of about 34 million euro.

Science and Technologies or Services

The areas in which the Central Veterinary Institute works cover the entire range of diseases (caused by viruses, bacteria, prions and parasites) found among agricultural livestock, fish and shellfish and wild animals. The Institute also studies pathogenic organisms in animals that form a threat to humans (zoonoses). Among the important topics of research and advice in this area of work are:

• diagnostics of animal diseases
• development and validation of diagnostic techniques
• development and testing of vaccines
• development and supervision of effective programmes to monitor, safeguard against and control of animal diseases
• host-pathogen interaction
• registration studies
• resistance to antibiotics
• workplace hygiene and chain quality
• product quality

Alliances

• Many European Veterinary Research Institutes
• Faculty of Veterinary Medicine, University Utrecht
• Animal Health Services, Deventer
• Other Research Institutes of Wageningen University and Research Centre

Keywords

• Veterinary sciences
• Dutch reference institute
• Veterinary vaccines
• Veterinary diagnostics
• Animal disease control programmes
• Registration Studies
• Intellectual Property

Zernikedreef 11
2333 CK Leiden
Website
E-mail
T +31 (0)71 518 8743
F +31 (0)71 518 8415

Employees: 6
Employees in R&D: 0
Year of foundation: 2007

Company Profile

CBD is a non-profit organization staffed by a small, dedicated group of lecturers affiliated to the Faculty of Technology in the University of Applied Sciences Leiden (Hogeschool Leiden). We possess a track record in successful postgraduate education of technical lab personnel, spanning over 20 years. Our main focus is to strengthen and modernize the theoretical and practical knowledge base of technical personnel involved in laboratory work in health care, pharmaceutical, industrial and forensic settings, thereby providing a secure basis for quality improvement. We also provide consultancy services for clients seeking to optimize lab tests and boost their quality assurance procedures.
Organisations who chose CBD for their schooling and training needs include VUmc, Crucell, Philips Healthcare Incubator, UMC Groningen, Naktuinbouw, Radboud University Medical Center, Vitens, Erasmus Medical Center and Heineken.

Science and Technologies or Services

CBD is active in the following areas of life science training and consultancy:

• Molecular biology/molecular diagnostics
• Microbiology/infectious diseases
• Immunology and immunochemistry
• Clinical chemistry and hematology
• Histology/pathology
• Agriculture/horticulture

CBD offers

• training courses for groups or individuals (at the University of Applied Sciences Leiden)
• incompany training trajectories, in which the course content is tailored to fit the schooling and quality improvement needs of the client
• consultancy services
• organization of conferences.

Alliances

• Toplab @ Hogeschool Leiden
• Naktuinbouw
• Boerhaave Nascholing, LUMC
• Symbiant

Keywords

• University of Applied Sciences Leiden
• life sciences
• postgraduate professional education
• in company training
• consultancy
• molecular biology/ molecular diagnostics
• microbiology/ infectious diseases
• immunology and immunochemistry
• clinical chemistry and hematology
• histology / pathology
• agriculture / horticulture

Erfocentrum De Bleek 13 3447 GV Woerden Website Stichting ERFO-Centrum E-mail Stichting ERFO-Centrum T +31 (0)348 43 76 90 F +31 (0)348 43 76 99 Employees in Amsterdam: 8 Employees in R&D: 0 Year of foundation: 2000

Company profile

National Education Centre for genetics, genetic diseases, preconception advice, genetic research and medical biotechnology.

Science and Technologies or Services

NA

Alliances

Among others NIGZ, VSOP.

Keywords

• Education;
• Information;
• Rare diseases;
• Genetic diseases;
• Preconcpetion care;
• Genetic research;
• Risk factors;
• Screening;
• Genetics.

Hans Mak Institute
Koningin Wilhelminalaan 29b
1411 EL Naarden
Website Hans Mak Institute
E-mail Hans Mak Institute
T +31 (0)35 678 30 00
F +31 (0)35 678 30 02

Employees in Amsterdam: 15
Employees in R&D: 10
Year of foundation: 2003

Company profile

The Hans Mak Institute (HMi) is an independent institute for quality management in the field of kidney diseases. It was founded in 2003 by the Dutch Kidney Foundation, the Dutch Renal Patient Association and the Dutch Federation of Nephrology. The scope of the HMi is to boost improvements in the quality of care throughout the ‘renal chain’, including patients with kidney diseases, chronic renal failure, pre-dialysis, dialysis and transplantation. Its goal is a coherent quality system embedding initiatives related to quality of care. The HMi supports and promotes these activities and starts new developments. To this purpose an important tool is the large experience of the HMi in facilitating and supporting clinical multi-centre studies and trials in nephrology. The HMi hosts large databases and is involved in national, European and global studies on genetic factors influencing the outcome of kidney disease. Furthermore the HMi is involved in new developments in the field of self management including new technical tools for self monitoring of clinical outcome and diagnostic parameters.

Science and Technologies or Services

The HMi is an expert in the execution of clinical trials including data management, monitoring by clinical research assistants and data analysis. The institute collaborates with national and international research institutes and with innovative enterprises being involved in nanotechnology and the development of domotica.

Alliances

The Hans Mak Institute cooperates with the Dutch Renal Patient Association, the Dutch Kidney Foundation and Dutch nephrologists. The HMi collaborates with all University Medical Centres in the Netherlands and (inter)national research institutes like Karolinska Institute Stockholm, Montréal Nephrology Consortium, Cardiovascular Research Univerity of Manchester, Charite Berlin, UCL medical School Brussels, Mario Negri Institute Bergamo, University Hospital Aachen. The HMi is involved in P3G (Public Population Project in Genomics, Canada) and cooperates with Medimate, Enschede in the development of technical devices for self monitoring of clinical parameters in kidney disease.

Keywords

• Kidney disease
• Quality of care
• Multi center studies
• Genomics
• Self management

Institute for Biodiversity and Ecosystem Dynamics (IBED) - UvA
Science Park 700
1098 XH Amsterdam
Website IBED
E-mail IBED
T +31 (0)20 525 66 35
F +31 (0)20 525 78 32

Employees in Amsterdam: 146
Employees in R&D: 98
Year of foundation: 2000

Company Profile

Science and Technologies or Services

Multidisciplinary research is needed to fulfil IBED's mission. Therefore, scientists trained in biology, chemistry, physical geography and environmental sciences work together. IBED's research is also characterized by a tight interplay between experimentation, data analyses and modelling. This fits well in the ambition of the Faculty of Science of the University to play a key role in the evolving field of e-Science, i.e. the utilization of modern computational techniques and analytical tools to tackle fundamental scientific problems. Progressively more initiatives of co-operations take advantage of the different disciplines present in IBED. The research of the Institute is organized in three themes: (1) Biodiversity and Evolution, (2) Geo-Ecology, and (3) Community Dynamics. Integrated research spanning all three Themes is actively promoted.

Keywords

• Evolutionary biology
• Experimental plant systematics
• Earth surface science
• Paleo ecology and landscape ecology
• Population bioloyg
• Aquatic ecology and ecotoxicology
• Aquatic microbiology
• Theoretical ecology

Dorshorst 2
7217 PH Harfsen
Website
E-mail
T +31 (0)573459981

Employees: 1
Employees in R&D: 2
Year of foundation: 2009

Company Profile

Private analytical research laboratorium which provides high-end and tailor made solutions to customers at a competitive price.

Science and Technologies or Services

Analytical chemistry service laboratorium and free lance consultants.

Alliances

Atas

Keywords

• analytical chemistry
• chromatography
• innovative research
• international projects

KIT Royal Tropical Institute/Dept. KIT Biomedical Research
Meibergdreef 39
1105 AZ Amsterdam
Website KIT Royal Tropical Institute
E-mail KIT Royal Tropical Institute
T +31 (0)20 566 54 41
F +31 (0)20 697 18 41

Employees in Amsterdam: 35
Employees in R&D: 35
Year of foundation: 1910

Company Profile

KIT Biomedical Research is a unique not-for-profit centre where science, product development and policy formulation are brought together to improve the detection of infectious diseases that threaten public health in low- and middle-income countries.
At KIT Biomedical Research we identify, design, develop, evaluate and implement such tools and develop guidelines and contribute to policy development for their rational use. The outcomes of this research regularly lead to out-sourcing of our expertise and materials in both public and private partnerships.
Our department is a multicultural environment, where approximately 35 people with professional backgrounds in immunology, microbiology, molecular biology, epidemiology, public health and quality assurance work together. This diversity has also led KIT Biomedical Research into other areas of expertise related to diagnostics, such as laboratory systems strengthening and advisory services.
It is the combination of basic science, diagnostic product development and implementation which allows us to address public health issues in a characteristic and comprehensive way that appeals to public and private partners in the fields of research, diagnostics, capacity building and advisory services.

Science and Technologies or Services

In the fight against infectious diseases, the improvement of diagnostic tests is dearly needed to fulfill needs of accessibility, affordability and better performance.
KIT Biomedical Research has a significant track record in test development in collaboration with industrial partners. We have developed several diagnostic tests, some of which are now considered worldwide as the gold standard (e.g. LeptoTek DriDot for leptospirosis). Hundreds of thousands of our tests have already found their way to developing countries. The simplicity and robustness of these tests make them especially suitable to be used as point-of-care tests outside the specialized laboratory.
We work closely together with partners in developing countries in many aspects of the diagnostic pipeline like need assessment, biomarker identification, test development and evaluation, and implementation. Partnerships with industrial partners who are able and willing to manufacture, market and distribute the tests are essential.
As the requirements for diagnostic tests are increasing, the technology enabling diagnostics is also improving. KIT Biomedical Research is proud to be amongst those at the scientific and technological forefront of diagnostics development; for several new tests and methods of testing we are using novel technologies, such as nanotechnology and sensor technology. Diagnostics based on these technologies have the potential to become very simple methods with high performance.
We also perform contract research for companies, provided the activities are within the scope of our mission.

Alliances

At KIT Biomedical Research we firmly believe that active partnerships are key in the fight against infectious diseases. As a result, we have an extensive global network of collaborations with laboratories, institutes, organisations and industrial partners in developing and industrialised countries. In Amsterdam we are partner in the Centre for Poverty-related Communicable Diseases (CPCD) in which AMC, PharmAccess, IATEC and KNCV work together.
Even closer to home, interdepartmental collaboration within the Institute, in particular with KIT Development Policy and Practice, is an added value to our work.

Keywords

• Essential diagnostics
• Diagnostic development
• Diagnostics evaluation
• Infectious diseases
• Public health
  
  
  

Einsteinstraat 35
3902 HN Veenendaal
Website
E-mail
T +31 318 501633
F +31 318 501640

Year of foundation: 2009

Company Profile

Micro-Serve supplies the total range of microbiological service specifically for the CE-mark sterile medical devices.
The services will consist of the full range of microbiological tests (e.g. sterility-testing, bioburden), validations and related services that are designed to client requirements and meet the respective ISO standards.

Science and Technologies or Services

sterility testing, bioburden, microscopic identifications, accelerated aging, microbiological sterilization validations

Keywords

• bioburden
• sterility
• ISO 11137
• ISO 11737
• microbiological testing of medical device

Netherlands Institute for Neuroscience (NIN)
Meibergdreef 47
1105 BA Amsterdam
Website NIN
E-mail NIN
T +31 (0)20 566 55 00
F +31 (0)20 566 61 21

Employees in Amsterdam: 160
Employees in R&D: 120
Year of foundation: 2005

Company Profile

Science and Technologies or Services

Fields of research are: Molecular Ophthalmogenetics, Hypothalamic Integration Mechanisms, Clinical Ophthalmogenetics, Cellular Quality Control, Retinal Signal Processing, Molecular Visual Plasticity, Vision and Cognition, Neuropsychiatric Diseases, Ocular Signal Transduction, Sleep and Cognition, Neuroregeneration, Neuromedical Genetics

Alliances

Keywords

• Cognition
• Brain function
• Visual system
• Degeneration and regeneration
• Therapeutic strategies
• Blindness
• Brain disease
• Eye disease

Netherlands Institute for Systems Biology
Science Park 904
1098 XH Amsterdam
Website Netherlands Institute for Systems Biology
E-mail Netherlands Institute for Systems Biology
T +31 (0)20 525 51 50
F +31 (0)20 525 79 35

Employees in Amsterdam: 47
Employees in R&D:
Year of foundation: 2007

Company profile

NISB research projects are characterised by the iterative cycle of experiment --> predictive quantitative model --> quantitative prediction --> experimental verification --> improved model --> et cetera. This approach ensures a systematic, goal-oriented and efficient tackling of key problems in the life sciences.

Science and Technologies or Services

The institute offers a platform to bring together researchers from various fields and institutes in the field of biology, mathematics, physics, and chemistry.

Alliances

• University of Amsterdam (UvA)
• VU University Amsterdam (VUA)
• The Netherlands Research Institute for Mathematics and Computer Science (CWI)
• FOM Institute for Atomic and Molecular Physics (AMOLF)

Keywords

• Systems Biology
• Metabolic Syndrome
• Diabetes
• Networks
• Genomics